The Weekly Update

Last week the yield on the 10-year US Treasury fell 9bps to 2.41%, mostly driven by Trump’s abandonment of the health care bill vote. In fact Trump-euphoria appeared to wane ahead of the AHCA vote, as the GOP are not in favour of replacing Obamacare; as such the dollar continued its retreat, with the DXY Index falling 0.67% over the week, back below $100 level as markets have been forced to rethink their pricing.

If we look back a few months ago Trump was the engine of economic and market change, and the markets consequently priced bond yields higher along with a stronger stock market. However, as we have argued a number of times Trump will have a problem with getting his reforms passed through the house. From our viewpoint Americans have voted for change and Trump appears to be just the change, however his appointments to key positions in his administration from the corporate sector is a big mistake. We have argued that 10-year bond yields above 2.5% is a buying opportunity and the stock market is very toppy, with an optimistic bias as the market assumes Trump will be able to effect some economy positive factors. However, we doubt the political situation will permit much change as politicians can always hide behind the huge budget deficit, when in fact they are going to force Trump into a box of frustration to teach him the political club really runs the USA. As expectations for future reform continue to hang in the balance, markets will look to focus on the outcome of the upcoming  tax overhaul bill.

Elsewhere, the UK is to trigger Article 50 on Mar 29th, this week Wednesday, while the Scottish debate on a second independence referendum will take place on Tuesday. Rating agency Moody’s highlights: ‘The credit implications of Brexit are likely to remain modest and manageable for most UK issuers in our base case scenario. This implies that rating implications may be limited for most UK-domiciled issuers’. Moody’s rates the UK Aa1, with negative outlook. With CPI surprising on the upside last week, up 2.3% in February, there has been some debate on whether rate normalisation should begin, however, with the huge unknowns surrounding Brexit negotiations, monetary policy is expected to remain unchanged in the short-term.

Elsewhere, ‘serial defaulter’ Argentina issued a 3.375% 2020 new issue, rated B3 by Moody’s; initially touted at CHF300m the deal was up-scaled to CHF400m. Despite Argentina being rated 4 stars on our NFA model this is not an issue we would look to hold. We have never held debt issued by Argentina mostly due to its past default history, the fact that it is rated sub-investment grade and has negative risk-adjusted expected returns, however, we always monitor the bond market. This was an interesting issue, as there was a huge amount of market demand with recent positive developments including: Moody’s recent rating outlook upgrade to positive from stable, and JP Morgan including Argentina in its EM local indices bucket. Argentina has always been a favourite with other investors as shown by the issues in April last year when they issued $16.5bn in new bonds with interest rumoured, at the time, to be in excess of $70bn.

Unfortunately we calculate that Argentina’s debt trades expensively, with the 7.625% 2046 trading at a spread around +450bps over USTs, where similar bonds trade at around 506bps over. This suggests that the market is actually pricing in further improvement and rating this particular B2 bond one notch higher, at B1. We have never held anything expensive on our portfolio, as this prices in more chance of a capital loss, in this case, over -6%. We would much rather hold USD debt issued by United Mexican States: where the A-/BBB+ rated 4.6% 2046 issue for example has an expected return and yield of over +14% and +2.2 credit notches of protection.

Looking to the week ahead there is little in the way of economic data releases from the US until Thursday, where we will get the third reading for Q4 growth and core PCE release. Of course Article 50 will take up European focus and we expect continued central bank comments throughout the week. In Asia, Japanese retail sales and CPI are due, but of more interest will be China’s PMI release on Friday. With little data and little scheduled central bank activity the markets should be relatively calm this week, but as always, look out for the unexpected.

Please read this important information before proceeding. It contains legal and regulatory notices relevant to the information on this site.

This website provides information about Stratton Street Capital LLP ("Stratton Street"). Stratton Street is authorised and regulated by the UK's Financial Conduct Authority. The content of this website has been prepared by Stratton Street from its records and is believed to be accurate but we do not accept any liability or responsibility in respect of the information of any views expressed herein. The information, material and content provided in the pages of this website may be changed at any time by us. Information on this website may be out of date and may not be updated or removed.

The website is provided for the main purpose of providing generic information on Stratton Street and on our investment philosophy for the use of financial professionals in the United Kingdom that qualify as Professional Clients or Eligible Counterparties under the rules of the United Kingdom Financial Conduct Authority (the "FCA"). The information in this website is not intended for the use of and should not be relied on by any person who would qualify as a Retail Client. Products and services referred to on this website are offered only at times when, and in jurisdictions where, they may be lawfully offered. The information on this website is not directed to any person in the United States. The provision of the information on this website does not constitute an offer to purchase securities to any person in the United States (other than a professional fiduciary acting for the account of a non-U.S person) or to any U.S. person as such term is defined under the Securities Act of 1933, as amended.

The website is not intended to offer investors the opportunity to invest in any Alternative Investment Fund ("AIF") product. The AIFs managed by Stratton Street are not being marketed in the European Economic Area ("EEA") and any eligible potential investor from the EEA who wishes to obtain information on the AIFs will only be provided with materials upon receipt by Stratton Street of an appropriate reverse solicitation request in accordance with the requirements of the EU Alternative Investment Fund Managers Directive ("AIFMD") and national law in their home jurisdiction. By proceeding you confirm that you are not accessing this website in the context of a potential investment by an EEA investor in the AIFs managed by Stratton Street and that you have read, understood and agree to these terms.

No information contained in this website should be deemed to constitute the provision of financial, investment or other professional advice in any way. The website should not be relied upon as including sufficient information to support any investment decision. If you are in doubt as to the appropriate course of action we recommend that you consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser. Past performance is not necessarily a guide to the future. The value of investments and the income from them may go down as well as up. An application for any investment or service referred to on this site may only be made on the basis of the offer document, key features, prospectus or other applicable terms relating to the specific investment or service.

Where we provide hypertext links to other locations on the Internet, we do so for information purposes only. We are not responsible for the content of any other websites or pages linked to or linking to this website. We have not verified the content of any such websites. Such websites may contain products and services that are not authorised in your jurisdiction. Following links to any other websites or pages shall be at your own risk and we shall not be responsible or liable for any damages or in other way in connection with linking.

By using this site, you should be aware that we may disclose any information that we hold about you to any regulatory authority to which we are subject, or to any person legally empowered to require such information.

This website uses cookies to improve user experience, by clicking the "I Accept" button below means you consent to the use of cookies on our website.